TCRX - TScan Therapeutics Revenue Growth YoY (Last 12 Months)

Public company logo of TScan Therapeutics Inc (TCRX)

The development of cellular cancer therapies creates a certain inertia, as the business relies on external capital without its own profitable products. The current year-over-year sales trend over 12 months confirms this dependency, where the parameter value equals -38.70. TScan Therapeutics (TCRX) leads in tumor receptor mapping while delegating production and clinical trials to external contractors.

TCRX tscan.com: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 11/17/2026

TScan Therapeutics, Inc. - analytical breakdowns and key metrics (TCRX)

- stock value and consensus price forecast:
Summary company analytics:tscan.com
Brand item of tscan.com

The stability of TScan Therapeutics (TCRX) depends exclusively on the success of T-cell therapy clinical trials. Mathematically, this is reflected in the revenue dynamics over the last twelve months. This metric captures the percentage change in revenue, measuring the pace of business expansion. For a biotech startup without commercial products, the annual revenue growth rate over a rolling four quarters often remains zero due to R&D expenses.

Who TScan Therapeutics competes with

Annual Revenue Growth (Last Twelve Months) BeiGene Corp (ONC)|HALO - Sales Growth YoY (Last Twelve Months)|RVMD: Sales Growth YoY (Last Twelve Months)|AAPG: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth CG Oncology Inc (CGON)|URGN (urogen.com) - Sales Growth YoY (TTM)|BCAX: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Personalis (PSNL)|Sales Growth YoY (TTM) Erasca (ERAS)|Sales Growth YoY (TTM) DCTH (Delcath Systems)|Revenue Dynamics YoY (Last Twelve Months) YMAB|AURA - Sales Growth YoY (Last Twelve Months)|candeltx.com - Revenue Change YoY (Last 12 Months)|ARAY: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Citius Oncology Inc. (CTOR)|Sales Growth YoY (Last Twelve Months) TuHURA (HURA)|TARA - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Trailing Twelve Months Revenue Growth|Champions Oncology, Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) XBiotech Inc XBIT|CVM: Sales Growth YoY (TTM)|OSTX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Radiopharm Theranostics Limited|Sales Growth YoY (TTM) artivabio.com|Revenue Growth YoY (Last 12 Months) ANL (Adlai Nortye Limited)|Veru - Sales Growth YoY (Last 12 Months)|Tempest Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) xiliotx.com (XLO)|Renovaro - Sales Growth YoY (TTM)|Mural Oncology (MURA) - Revenue Growth YoY (Last 12 Months)|KAPA: Sales Growth YoY (TTM)|OKUR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) CytoMed Therapeutics Limited|CRIS: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) APLM|Sales Growth YoY (TTM) tharimmune.com (THAR)|Advanced Biomed Corp - Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) GNPX|Calidi Biotherapeutics, Inc. - Sales Growth YoY (TTM)|Sunshine Biopharma (SBFM) - Revenue Growth YoY (Last 12 Months)|XBIO: Sales Growth YoY (TTM)|SLRX - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PPBT|Sales Growth YoY (TTM) American Oncology Network|Sales Growth YoY (Last Twelve Months) BeOne Medicines (BGNE)|CKPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ELEV (Elevation Oncology Inc.)|Sales Growth YoY (TTM) iCAD Corp ICAD|Ikena - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) NTBL (Notable Labs)|VIRX: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth MOR (MorphoSys Corp)|Sales Growth YoY (Last Twelve Months) NAYA Biosciences|Sales Growth YoY (TTM) ascentage.com